PTHS Latest Press Releases

-- November 4, 2026 --

Pelthos Therapeutics to Report Third Quarter 2026 Financial Results on November 12, 2026 Globe Newswire 4:05 PM

-- October 30, 2026 --

Pelthos Therapeutics to Combine with Castle Creek Biosciences, Creating Transformative Biotechnology Company Focused on Serious Diseases that Affect the Skin Globe Newswire 9:09 AM

-- October 27, 2026 --

Altimmune Appoints Peter Greenleaf and Alex Howarth, Two Leading Biotech Executives, to Board of Directors to Support Its Strategic Evolution Globe Newswire 8:00 AM

-- October 6, 2026 --

Pelthos Therapeutics Announces Expanded Formulary Coverage for ZELSUVMI (berdazimer) Topical Gel, 10.3% Globe Newswire 8:00 AM

-- August 13, 2026 --

Pelthos Therapeutics Announces Second Quarter 2026 Financial Results Globe Newswire 7:10 AM

-- August 3, 2026 --

Pelthos Therapeutics to Report Second Quarter 2026 Financial Results on August 13, 2026 Globe Newswire 8:00 AM

-- July 24, 2026 --

Pelthos Therapeutics Announces 2026 Annual Meeting of Stockholders Globe Newswire 5:00 PM

-- June 30, 2026 --

Pelthos Therapeutics Added to Russell 3000E Growth Benchmark, Russell Microcap and Russell Microcap Growth Benchmark Indexes Globe Newswire 4:15 PM

Palvella Therapeutics Appoints Accomplished Rare Disease Biotech Executive and Commercial Leader Matt Pauls, J.D., M.B.A., to Board of Directors Globe Newswire 7:30 AM

Market Data Delayed 15 Minutes